Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy | European Journal of Medical Research | Full Text
Cureus | Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management | Article
Light Chain-Associated Renal Disorders: Practice Essentials, Pathophysiology, Etiology
Phenotyping Polyclonal Kappa and Lambda Light Chain Molecular Mass Distributions in Patient Serum Using Mass Spectrometry | Journal of Proteome Research
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Light Chain Deposition Disease | UNC Kidney Center
Cureus | Light-Chain Multiple Myeloma: A Diagnostic Challenge | Article
Removal of free light chains in hemodialysis patients without multiple myeloma: a crossover comparison of three different dialyzers – topic of research paper in Biological sciences. Download scholarly article PDF and read
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | Leukemia
Curing Cast Nephropathy by Removing Not-so-light Chains? — NephJC
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Correspondence data for kappa and lambda free light chain analysis | Download Table
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy | PLOS ONE
Measuring Serum Free Light Chains (FLC) Improves Diagnosis and Prognosis for Patients with Monclonal Gammopathies - Warde Medical Laboratory
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Discrepancy in serum free light chain analysis compared with serum... | Download Scientific Diagram
Table 1 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients - ScienceDirect
Serum Free Light Chain Assay - Renal Fellow Network
Biomedicines | Free Full-Text | Serum Free Light-Chain Ratio at Diagnosis Is Associated with Early Renal Damage in Multiple Myeloma: A Case Series Real-World Study
Manni Mohyuddin on Twitter: "So as a junior myeloma faculty, I see a lot of consults for MGUS. Heres a tweetorial on how to interpret light chain values in the setting of
The biology of immunoglobulin free light chains and kidney injury - ScienceDirect
![PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/1444d9fcd1aa06934208ca29e69340f3ca084cbe/3-Table4-1.png "PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar")
PDF] Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Article: Monoclonal gammopathy of renal significance (MGRS) histopathologic classification, diagnostic workup, and therapeutic options (full text) - September 2019 - NJM
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
